Peterlabs Holdings Bhd (XKLS:0171) 3-Year EBITDA Growth Rate : -5.00% (As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Peterlabs Holdings Bhd 3-Year EBITDA Growth Rate?

Peterlabs Holdings Bhd's EBITDA per Share for the three months ended in Mar. 2024 was RM0.01.

During the past 12 months, Peterlabs Holdings Bhd's average EBITDA Per Share Growth Rate was 29.40% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -5.00% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was -5.60% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 1.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Peterlabs Holdings Bhd was 12.80% per year. The lowest was -20.60% per year. And the median was 2.90% per year.

Competitive Comparison of Peterlabs Holdings Bhd's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Peterlabs Holdings Bhd's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Peterlabs Holdings Bhd's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Peterlabs Holdings Bhd's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Peterlabs Holdings Bhd's 3-Year EBITDA Growth Rate falls into.

Peterlabs Holdings Bhd 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Peterlabs Holdings Bhd (XKLS:0171) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Peterlabs Holdings Bhd 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Peterlabs Holdings Bhd's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Peterlabs Holdings Bhd (XKLS:0171) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Peterlabs Holdings Bhd (XKLS:0171) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

Jalan Nilam 3, Lot 16014 (PT No. 24341), Bandar Nilai Utama, Nilai, NSN, MYS, 71800

Website

https://www.peterlabs.com.my

Peterlabs Holdings Bhd is a Malaysia based company engaged in manufacturing, distribution, and trading of animal health and nutrition products. It also provides solutions like farm management, technical advisory services, raw material analysis and feed formulation. The operating segments of the group are Manufacturing which relates to manufacturing of animal health and nutrition products, and Trading which relates to trading and distribution of animal health and nutrition products. It offers products like animal feed additives, veterinary pharmaceuticals, injectable products, multi-nutrient and supplement, topical dressings, cleansing agents, and other related products. The company operates in Malaysia and internationally, and generates key revenue from the Trading segment.

Peterlabs Holdings Bhd (XKLS:0171) Headlines

No Headlines